|
1
|
Zhang S, Ji G and Liu J: Reversal of
chemical-induced liver fibrosis in Wistar rats by puerarin. J Nutr
Biochem. 17:485–491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yeung DK, Leung SW, Xu YC, Vanhoutte PM
and Man RY: Puerarin, an isoflavonoid derived from Radix puerariae,
potentiates endothelium-independent relaxation via the cyclic AMP
pathway in porcine coronary artery. Eur J Pharmacol. 552:105–111.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Q, Xiao Y, Gong H, Shen D, Zhu F, Wu Q,
Chen H and Zhong H: Effect of puerarin on the expression of
extracellular matrix in rats with streptozotocin-induced diabetic
nephropathy. Natl Med J India. 22:9–12. 2009.PubMed/NCBI
|
|
4
|
Guerra MC, Speroni E, Broccoli M, Cangini
M, Pasini P, Minghett A, Crespi-Perellino N, Mirasoli M,
Cantelli-Forti G and Paolini M: Comparison between Chinese medical
herb Pueraria lobata crude extract and its main isoflavone puerarin
antioxidant properties and effects on rat liver CYP-catalysed drug
metabolism. Life Sci. 67:2997–3006. 2000. View Article : Google Scholar
|
|
5
|
Yan LP, Chan SW, Chan AS, Chen SL, Ma XJ
and Xu HX: Puerarin decreases serum total cholesterol and enhances
thoracic aorta endothelial nitric oxide synthase expression in
diet-induced hypercholesterolemic rats. Life Sci. 79:324–330. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han RM, Tian YX, Becker EM, Andersen ML,
Zhang JP and Skibsted LH: Puerarin and conjugate bases as radical
scavengers and antioxidants: molecular mechanism and synergism with
beta-carotene. J Agric Food Chem. 55:2384–2391. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao M, Du YQ, Yuan L and Wang NN:
Protective effect of puerarin on acute alcoholic liver injury. Am J
Chin Med. 38:241–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang X, Hu W, Zhang Q, Wang Y and Sun L:
Puerarin inhibits C-reactive protein expression via suppression of
nuclear factor kappaB activation in lipopolysaccharide-induced
peripheral blood mononuclear cells of patients with stable angina
pectoris. Basic Clin Pharmacol Toxicol. 107:637–642. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim KM, Jung DH, Jang DS, Kim YS, Kim JM,
Kim HN, Surh YJ and Kim JS: Puerarin suppresses AGEs-induced
inflammation in mouse mesangial cells: a possible pathway through
the induction of heme oxygenase-1 expression. Toxicol Appl
Pharmacol. 244:106–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng P, Ji G, Ma Z, Liu T, Xin L, Wu H,
Liang X and Liu J: Therapeutic effect of puerarin on non-alcoholic
rat fatty liver by improving leptin signal transduction through
JAK2/STAT3 pathways. Am J Chin Med. 37:69–83. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh AK, Jiang Y, Benlhabib E and Gupta
S: Herbal mixtures consisting of puerarin and either
polyenylphosphatidylcholine or curcumin provide comprehensive
protection against alcohol-related disorders in P rats receiving
free choice water and 15% ethanol in pure water. J Med Food.
10:526–542. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiong FL, Sun XH, Gan L, Yang XL and Xu
HB: Puerarin protects rat pancreatic islets from damage by hydrogen
peroxide. Eur J Pharmacol. 529:1–7. 2006. View Article : Google Scholar
|
|
13
|
Cheng YF, Zhu GQ, Wang M, Cheng H, Zhou A,
Wang N, Fang N, Wang XC, Xiao XQ, Chen ZW and Li QL: Involvement of
ubiquitin proteasome system in protective mechanisms of puerarin to
MPP(+)-elicited apoptosis. Neurosci Res. 63:52–58. 2009. View Article : Google Scholar
|
|
14
|
Bo J, Ming BY, Gang LZ, Lei C and Jia AL:
Protection by puerarin against MPP+-induced
neurotoxicity in PC12 cells mediated by inhibiting mitochondrial
dysfunction and caspase-3-like activation. Neurosci Res.
53:183–188. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu X and Zheng X: Potential involvement of
calcium and nitric oxide in protective effects of puerarin on
oxygen-glucose deprivation in cultured hippocampal neurons. J
Ethnopharmacol. 113:421–426. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mercer LD, Kelly BL, Horne MK and Beart
PM: Dietary polyphenols protect dopamine neurons from oxidative
insults and apoptosis: investigations in primary rat mesencephalic
cultures. Biochem Pharmacol. 69:339–345. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chung MJ, Sung NJ, Park CS, Kweon DK,
Mantovani A, Moon TW, Lee SJ and Park KH: Antioxidative and
hypocholesterolemic activities of water-soluble puerarin glycosides
in HepG2 cells and in C57 BL/6J mice. Eur J Pharmacol. 578:159–170.
2008. View Article : Google Scholar
|
|
18
|
Angulo P: Nonalcoholic fatty liver
disease. N Engl J Med. 346:1221–1231. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
American Gastroenterology Association:
American Gastroenterological Association medical position
statement: nonalcoholic fatty liver disease. Gastroenterology.
123:1702–1704. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koteish A and Diehl AM: Animal models of
steatosis. Semin Liver Dis. 21:89–104. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Satia-Abouta J, Patterson RE, Schiller RN
and Kristal AR: Energy from fat is associated with obesity in U.S.
men: results from the Prostate Cancer Prevention Trial. Prev Med.
34:493–501. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shimano H, Yahagi N, Amemiya-Kudo M, Hasty
AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K,
Gotoda T, Ishibashi S and Yamada N: Sterol regulatory
element-binding protein-1 as a key transcription factor for
nutritional induction of lipogenic enzyme genes. J Biol Chem.
274:35832–35839. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aggarwal BB: Targeting
inflammation-induced obesity and metabolic diseases by curcumin and
other nutraceuticals. Annu Rev Nutr. 30:173–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brown MS and Goldstein JL: The SREBP
pathway:regulation of cholesterol metabolism by proteolysis of a
membrane-bound transcription factor. Cell. 89:331–340. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Berger JP, Akiyama TE and Meinke PT:
PPARs: therapeutic targets for metabolic disease. Trends Pharmacol
Sci. 26:244–251. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou G, Myers R, Li Y, Chen Y, Shen X,
Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N,
Hirshman MF, Goodyear LJ and Moller DE: Role of AMP-activated
protein kinase in mechanism of metformin action. J Clin Invest.
108:1167–1174. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
You M, Matsumoto M, Pacold CM, Cho WK and
Crabb DW: The role of AMP-activated protein kinase in the action of
ethanol in the liver. Gastroenterology. 127:1798–1808. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsukamoto H, She H, Hazra S, Cheng J and
Miyahara T: Anti-adipogenic regulation underlies hepatic stellate
cell trans-differentiation. J Gastroenterol Hepatol. 21(Suppl 3):
S102–S105. 2006. View Article : Google Scholar
|
|
30
|
Kang OH, Kim SB, Seo YS, Joung DK, Mun SH,
Choi JG, Lee YM, Kang DG, Lee HS and Kwon DY: Curcumin decreases
oleic acid-induced lipid accumulation via AMPK phosphorylation in
hepatocarcinoma cells. Eur Rev Med Pharmacol Sci. 17:2578–2586.
2013.PubMed/NCBI
|
|
31
|
Shao W, Yu Z, Chiang Y, Yang Y, Chai T,
Foltz W, Lu H, Fantus IG and Jin T: Puerarin prevents high fat diet
induced insulin resistance and obesity via attenuating lipogenesis
in liver and inflammatory pathway in adipocytes. PLoS One.
7:e287842012. View Article : Google Scholar
|
|
32
|
Roche H, Zampelas A, Knapper JM, Webb D,
Brooks C, Jackson KG, Wright JW, Gould BJ, Kafatos A, Gibney MJ and
Williams CM: Effect of long-term olive oil dietary intervention on
postprandial triacylglycerol and factor VII metabolism. Am J Clin
Nutr. 68:552–560. 1998.PubMed/NCBI
|
|
33
|
Moreno JJ and Mitjavila MT: The degree of
unsaturation of dietary fatty acids and the development of
atherosclerosis (review). J Nutr Biochem. 14:182–189. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kirimlioglu V, Kirimlioglu H, Yilmaz S,
Ozgor D, Coban S, Karadag N and Yologlu S: Effect of fish oil,
olive oil, and vitamin E on liver pathology, cell proliferation,
and antioxidant defense system in rats subjected to partial
hepatectomy. Transplant Proc. 38:564–567. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Winder WW and Hardie DG: AMP-activated
protein kinase, a metabolic master switch: possible roles in type 2
diabetes. Am J Physiol. 277:E1–E10. 1999.PubMed/NCBI
|
|
36
|
Brooks SC III, Brooks JS, Lee WH, Lee MG
and Kim SG: Therapeutic potential of dithiolethiones for hepatic
diseases. Pharmacol Ther. 124:31–43. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hwang JT, Park IJ, Shin JI, Lee YK, Lee
SK, Baik HW, Ha J and Park OJ: Genistein, EGCG, and capsaicin
inhibit adipocyte differentiation process via activating
AMP-activated protein kinase. Biochem Biophys Res Commun.
338:694–699. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Auger C, Teissedre PL, Gerain P, Lequeux
N, Bornet A, Serisier S, Besançon P, Caporiccio B, Cristol JP and
Rouanet JM: Dietary wine phenolics catechin, quercetin, and
resveratrol efficiently protect hypercholesterolemic hamsters
against aortic fatty streak accumulation. J Agric Food Chem.
53:2015–2021. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Weng MS, Ho CT, Ho YS and Lin JK:
Theanaphthoquinone inhibits fatty acid synthase expression in
EGF-stimulated human breast cancer cells via the regulation of
EGFR/ErbB-2 signaling. Toxicol Appl Pharmacol. 218:107–118. 2007.
View Article : Google Scholar
|
